Cameron Chan

Stocks Roundup: The Gap, Inc. (GPS), Viavi Solutions Inc. (VIAV), Mattel, Inc. (MAT)

The Gap, Inc. (GPS) retreated with the stock falling -3% or $-0.73 to close at $23.63 on light trading volume of 5.82M compared its three months average trading volume of 6.56M. The San Francisco California 94105 based company operating under the Apparel Stores industry has been trending up for the last 52 weeks, with the shares price now 3.57% up for the period and up by 5.3% so far this year. With price target of $25.52 and a 43.44% rebound from 52-week low, The Gap, Inc. has plenty of upside potential, making it a hold with a view buy.

The Gap, Inc. operates as an apparel retail company worldwide. It offers apparel, accessories, and personal care products for men, women, and children under the Gap, Banana Republic, Old Navy, Athleta, and Intermix brands. The company provides apparel, eyewear, jewelry, shoes, handbags, and fragrances; and performance and lifestyle apparel for use in yoga, strength training, and running, as well as seasonal sports, including skiing and tennis. The Gap, Inc. offers its products through company-operated stores, franchise stores, Websites, e-commerce and social media sites, and catalogs. The company has franchise agreements with unaffiliated franchisees to operate Gap, Banana Republic, and Old Navy stores in Asia, Australia, Europe, Latin America, the Middle East, and Africa. As of November 17, 2016, it operated 3,300 company-operated stores and 450 franchise stores. The company was founded in 1969 and is headquartered in San Francisco, California.

Viavi Solutions Inc. (VIAV) had a active trading with around 5.79M shares changing hands compared to its three month average trading volume of 2.51M. The stock traded between $10.29 and $10.64 before closing at the price of $10.58 with 3.52% change on the day. The Milpitas California 95035 based company is currently trading 83.04% above its 52 week low of $5.78 and 1.34% above its 52 week high of $10.64. Both the RSI indicator and target price of  and $9.46 respectively, lead us to believe that it could rise over the coming weeks.

Viavi Solutions Inc. provides network test, monitoring, and assurance solutions to communications service providers, and enterprises and their ecosystems worldwide. The company operates through Network Enablement, Service Enablement, and Optical Security and Performance Products segments. The Network Enablement segment offers testing solutions that access the network to perform build-out and maintenance tasks. This segment provides solutions that include instruments, software and services to design, build, activate, certify, troubleshoot, and optimize networks. It also offers support and professional services, such as repair, calibration, software support, and technical assistance for the products; and system integration projects comprising project management, installation, and implementation, as well as product and technology training, and consulting services. The Service Enablement segment provides embedded systems and enterprise performance management solutions for communication service providers and enterprises with visibility into network, service, and application. This segment’s solutions include instruments, microprobes, and software, which monitor, collect, and analyze network data to reveal the actual customer experience and to identify opportunities for new revenue streams and network optimization. The Optical Security and Performance Products segment provides optical security solutions with a strategic focus on serving the anti-counterfeiting market through advanced security pigments, thread substrates, and printed features for the currency, pharmaceutical, and consumer electronic sectors. This segment also offers thin-film coating solutions for 3D sensing applications. The company was formerly known as JDS Uniphase Corporation and changed its name to Viavi Solutions Inc. in August 2015. Viavi Solutions Inc. was founded in 1979 and is headquartered in Milpitas, California.

Mattel, Inc. (MAT) saw its value increase by 0.7% as the stock gained $0.18 to finish the day at a closing price of $25.91. The stock was higher in trading and has fluctuated between $25.17-$34.76 per share for the past year. The shares, which traded within a range of $25.55 to $26.05 during the day, are down by -14.55% in the past three months and down by -22.12% over the past six months. It is currently trading -6.7% below its 20 day moving average and -9.62% below its 50 day moving average. Analysts believe the company can continue to increase in value to reach at $31.27 a share over the next twelve months. The current relative strength index (RSI) reading is 35.74.The technical indicator lead us to believe there will be no major movement any time soon, hold.

Mattel, Inc. designs, manufactures, and markets a range of toy products worldwide. The company operates in three segments: North America, International, and American Girl. It offers dolls and accessories, vehicles and play sets, and games and puzzles under the Mattel Girls & Boys brands, including Barbie, Monster High, Disney Classics, Ever After High, Little Mommy, Polly Pocket, Hot Wheels, Matchbox, CARS, Disney Planes, BOOMco, Radica, Toy Story, Max Steel, WWE Wrestling, and DC Comics. The company also provides its products under the Fisher-Price brands, such as Fisher-Price, Little People, BabyGear, Laugh & Learn, Imaginext, Thomas & Friends, Dora the Explorer, Mickey Mouse Clubhouse, Disney Jake, the Never Land Pirates, and Power Wheels. In addition, it offers its products under the American Girl brands comprising Truly Me, BeForever, and Bitty Baby; and construction, and arts and crafts brands, such as MEGA BLOKS, RoseArt, and Board Dudes, as well as publishes the American Girl magazine. Mattel, Inc. sells its products directly to consumers via its catalog, Website, and proprietary retail stores, as well as directly to retailers, including discount and free-standing toy stores, chain stores, department stores, and other retail outlets; to wholesalers; and through agents and distributors. The company was founded in 1945 and is headquartered in El Segundo, California.

 

Stocks Alert: Novavax, Inc. (NVAX), Peregrine Pharmaceuticals, Inc. (PPHM), Spirit Realty Capital, Inc. (SRC)

Novavax, Inc. (NVAX) grew with the stock adding 2.24% or $0.03 to close at $1.37 on light trading volume of 5.32M compared its three months average trading volume of 6.53M. The Gaithersburg Maryland 20878 based company operating under the Biotechnology industry has been trending down for the last 52 weeks, with the shares price now -70.28% down for the period and up by 8.73% so far this year. With price target of $3.29 and a 18.1% rebound from 52-week low, Novavax, Inc. has plenty of upside potential, making it a hold with a view buy.

Novavax, Inc., a clinical-stage vaccine company, focuses on discovering, developing, and commercializing recombinant nanoparticle vaccines and adjuvants. The company produces its vaccines using its proprietary recombinant nanoparticle vaccine technology. Its product pipeline includes respiratory syncytial virus (RSV) vaccine candidates for elderly and maternal immunization that are in Phase III clinical trials, as well as pediatric RSV candidate, which is in Phase I clinical trial; seasonal quadrivalent influenza and pandemic H7N9 vaccines, which are in Phase II clinical trials; vaccine candidate against Ebola Virus that is Phase I clinical trial, as well as combination respiratory vaccine candidate and seasonal influenza vaccine candidate that is in pre-clinical trial; and rabies G protein vaccine candidate, which is in Phase I/II clinical trial. The company also has pre-clinical stage programs for various infectious diseases, including the Middle East respiratory syndrome coronavirus; and develops technology for the production of immune stimulating saponin-based adjuvants. Novavax, Inc. was founded in 1987 and is headquartered in Gaithersburg, Maryland.

Peregrine Pharmaceuticals, Inc. (PPHM) gained $0.01 to close the day at a new closing price of $0.37, a 3.84% increase in value from its previous closing price that moved the stock 32.21% above its 52 week low of $0.282. A total of 5.31M shares exchanged hands during the day compared with its three month average trading volume of 2.01M. The stock, which fluctuated between $0.3553 and $0.3825 during the day, currently situated -66.95% below its 52 week high. The stock is up by 27.66% in the past one month and up by 15.69% over the past three months. With a one year target estimate of $1.25 and RSI of 73.74, the stock still has upside potential, making it a sell for now.

Peregrine Pharmaceuticals, Inc., a biopharmaceutical company, researches and develops monoclonal antibodies for the treatment of cancer in the United States. It’s lead immunotherapy candidate bavituximab, a monoclonal antibody that targets and binds to phosphatidylserine. The company also provides integrated current good manufacturing practices services from cell line development to commercial bio manufacturing for its third-party customers. In addition, its services comprise cGMP clinical and commercial manufacturing utilizing stainless steel and single use bioreactor technology, purification, bulk packaging, stability testing, regulatory strategy and related support. The company has license agreements with the University of Texas Southwestern Medical Center at Dallas; Genentech, Inc.; Avanir Pharmaceuticals, Inc.; Lonza Biologics; Affitech A/S; Merck KGaA; and National Comprehensive Cancer Network, as well as collaboration agreement with AstraZeneca PLC and Memorial Sloan Kettering Cancer Center. Peregrine Pharmaceuticals, Inc. was founded in 1981 and is headquartered in Tustin, California.

Spirit Realty Capital, Inc. (SRC) shares were down in last trading by -0.09% to $10.84. It experienced higher than average volume on day. The stock increased in value by almost 2.26% over the past week and fell -1.63% in the past month. It is currently trading 1.54% above its 50 day moving average and -7.24% below its 200 day moving average. Following the recent decrease in price, the stock’s new closing price represents a -20.03% decrease in value from its one year high of $13.97. The RSI indicator value of 55.08, lead us to believe that it is a hold for now.

Spirit Realty Capital, Inc. is a publicly traded real estate investment trust. The firm primarily acquires across the United States single tenant operationally essential real estate, which refers to generally free-standing, commercial real estate facilities where tenants conduct retail, service or distribution activities that are essential to the generation of their sales and profits. The firm was formerly known as Spirit Finance Corp. Spirit Realty Capital, Inc. was formed on August 14, 2003 and is domiciled in the United States.

 

Stocks in Focus: Under Armour, Inc. (UA), Sabre Corporation (SABR), Skechers U.S.A., Inc. (SKX)

Under Armour, Inc. (UA) had a light trading with around 4.71M shares changing hands compared to its three month average trading volume of 5.15M. The stock traded between $18.53 and $19.26 before closing at the price of $18.65 with -2.05% change on the day. The Baltimore Maryland 21230 based company is currently trading 4.95% above its 52 week low of $17.77 and -61.11% below its 52 week high of $46.2. Both the RSI indicator and target price of 26.03 and $23 respectively, lead us to believe that it could rise over the coming weeks.

Under Armour, Inc. together with its subsidiaries, develops, markets, and distributes branded performance apparel, footwear, and accessories for men, women, and youth primarily in North America, Europe, the Middle East, Africa, the Asia-Pacific, and Latin America. The company offers its apparel in compression, fitted, and loose types to be worn in hot, cold, and in between the extremes. It provides various footwear products, including football, baseball, lacrosse, softball and soccer cleats, slides, performance training, running, basketball, and outdoor footwear. The company also offers accessories, which include headwear, bags, and gloves; and digital fitness platform licenses and subscriptions, as well as digital advertising, as well as licenses its brands. It primarily provides its products under the UA Logo, UNDER ARMOUR, UA, ARMOUR, HEATGEAR, COLDGEAR, ALLSEASONGEAR, PROTECT THIS HOUSE, and I WILL, as well as ARMOURBITE, ARMOURSTORM, ARMOUR FLEECE, and ARMOUR BRA trademarks. The company sells its products through wholesale channels, including national and regional sporting goods chains, independent and specialty retailers, department store chains, institutional athletic departments, and leagues and teams, as well as independent distributors; and directly to consumers through a network of brand and factory house stores, and Website. Under Armour, Inc. was founded in 1996 and is headquartered in Baltimore, Maryland.

Sabre Corporation (SABR) failed to extend gains with the stock declining -2.2% or $-0.5 to close the day at $22.27 on active trading volume of 4.62M shares, compared to its three month average trading volume of 2.88M. The Southlake Texas 76092 based company has been underperforming the information technology services group over the past 52 weeks, with the stock losing -12.35%, compared to the industry which has advanced 39.61% over the same period. With RSI of 29.16, the stock should still continue to rise and get closer to its one year target estimate of $27, making it a hold for now.

Sabre Corporation provides technology solutions to the travel and tourism industry. The company operates through two segments, Travel Network, and Airline and Hospitality Solutions. The Travel Network segment operates a business-to-business travel marketplace that offers travel content, such as inventory, prices, and availability from a range of travel suppliers, including airlines, hotels, car rental brands, rail carriers, cruise lines, and tour operators with a network of travel buyers comprising online and offline travel agencies, travel management companies, and corporate travel departments. The Airline and Hospitality Solutions segment offers a portfolio of software technology products and solutions through software-as-a-service and hosted delivery models to airlines, hotel properties, and other travel suppliers. This segment provides SabreSonic Customer Sales & Service, a reservation system that provides capabilities around managing sales and customer service across an airline’s diverse touch points; Sabre AirVision Marketing & Planning, a set of airline commercial planning solutions; and Sabre AirCentre Enterprise Operations, a set of solutions for the holistic planning and management of airline, airport, and customer operations. In addition, this segment offers software and solutions to hotel properties comprising central reservation system, property management solution, and marketing and consulting services. Sabre Corporation was founded in 2006 and is headquartered in Southlake, Texas.

Skechers U.S.A., Inc. (SKX) shares were down in last trading by -2.84% to $26.99. It experienced higher than average volume on day. The stock increased in value by almost 16.04% over the past week and grew 5.8% in the past month. It is currently trading 7.34% above its 50 day moving average and 4.84% above its 200 day moving average. Following the recent decrease in price, the stock’s new closing price represents a -21.24% decrease in value from its one year high of $34.27. The RSI indicator value of 61.73, lead us to believe that it is a hold for now.

Skechers U.S.A., Inc. designs, develops, markets, and distributes footwear for men, women, and children; and performance footwear for men and women under the Skechers GO brand name worldwide. It operates through three segments: Domestic Wholesale Sales, International Wholesale Sales, and Retail Sales. The company offers casual footwear, including boots, shoes, and sandals for men, as well as oxfords and slip-ons, lug outsole and fashion boots, and casual sandals for women; dress casuals, seasonal sandals and boots, and relaxed fit casuals for men and women; and casual fusion line for young men and women under the Skechers USA brand. It also provides footwear collection for men and women, including lightweight sport athletic lifestyle products, classic athletic-inspired styles, and sport sandals and boots under the Skechers Sport brand name; casual and sporty styles sneakers for females under the Skechers Active and Skechers Sport Active brand; and footwear for women and girls under the BOBS from Skechers name. In addition, the company offers casual, dress, and active styles, as well as casual sneakers for men under the Mark Nason name; technical footwear under the Skechers Performance brand; and boots, shoes, sneakers, and sandals for infants, toddlers, boys, and girls under the Skechers Kids name. Further, it provides men’s and women’s casuals, such as field boots, hikers, and athletic shoes under the Skechers Work brand. The company sells its products through approximately 1,545 company-owned and third-party retail stores; and department and specialty stores, as well as through its e-commerce Website in approximately 160 countries and territories. Skechers U.S.A., Inc. was founded in 1992 and is headquartered in Manhattan Beach, California.

 

Equities Trend Analysis: Patterson-UTI Energy, Inc. (PTEN), Ciena Corporation (CIEN), Tidewater Inc. (TDW)

Patterson-UTI Energy, Inc. (PTEN) grew with the stock adding 2.62% or $0.73 to close at $28.62 on light trading volume of 3.56M compared its three months average trading volume of 3.94M. The Houston Texas 77067 based company operating under the Oil & Gas Drilling & Exploration industry has been trending up for the last 52 weeks, with the shares price now 119.76% up for the period and up by 6.32% so far this year. With price target of $27.87 and a 144.32% rebound from 52-week low, Patterson-UTI Energy, Inc. has plenty of upside potential, making it a hold with a view buy.

Patterson-UTI Energy, Inc., through its subsidiaries, provides onshore contract drilling services to major and independent oil and natural gas operators in the United States and Canada. The company operates through three segments: Contract Drilling, Pressure Pumping, and Oil and Natural Gas. The Contract Drilling segment markets its contract drilling services primarily in Texas, New Mexico, Louisiana, Colorado, Wyoming, North Dakota, Oklahoma, Pennsylvania, Ohio, West Virginia, and western Canada. As of December 31, 2015, this segment had a drilling fleet of 221 marketable land-based drilling rigs. The Pressure Pumping segment offers pressure pumping services that consist of well stimulation and cementing for the completion of new wells and remedial work on existing wells, as well as hydraulic and nitrogen fracturing, cementing, and acid pumping services in Texas and the Appalachian region. The Oil and Natural Gas segment owns and invests in oil and natural gas assets as a non-operating working interest owner located principally in Texas and New Mexico. Patterson-UTI Energy, Inc. was founded in 1978 and is headquartered in Houston, Texas.

Ciena Corporation (CIEN) had a active trading with around 3.53M shares changing hands compared to its three month average trading volume of 2.63M. The stock traded between $25.1 and $25.72 before closing at the price of $25.54 with 2.24% change on the day. The Hanover Maryland 21076 based company is currently trading 63.51% above its 52 week low of $15.61 and 0.87% above its 52 week high of $25.72. Both the RSI indicator and target price of  and $28.39 respectively, lead us to believe that it could rise over the coming weeks.

Ciena Corporation provides equipment, software, and services that support the transport, switching, aggregation, service delivery, and management of voice, video, and data traffic on communications networks worldwide. The company’s Networking Platforms segment offers hardware networking solutions optimized for the convergence of coherent optical transport, optical transport network switching, and packet switching. Its products include 6500 Packet-Optical Platform and the 5430 Reconfigurable Switching System, Waveserver stackable interconnect system, CoreDirector Multiservice Optical Switches, and OTN configuration for the 5410 Reconfigurable Switching System, as well as Z-Series Packet-Optical Platform; 3000 family of service delivery switches and service aggregation switches, and the 5000 family of service aggregation switches, as well as 8700 Packetwave Platform and the Ethernet packet configuration for the 5410 Service Aggregation Switch; and 4200 Advanced Services Platform, Corestream 5100/5200 Advanced Services Platform, Common Photonic Layer, and 6100 Multiservice Optical Platform. This segment also sells operating system software and enhanced software features embedded in each of these products. The company’s Software and Software-Related Services segment offers network management solutions, including the OneControl Unified Management System, ON-Center Network & Service Management Suite, Ethernet Services Manager, Optical Suite Release, and Planet Operate; and Blue Planet network virtualization, service orchestration, and network management software platform, as well as related installation, support, and consulting services. Its Global Services segment provides consulting and network design, installation and deployment, maintenance support, and training services. The company sells its products through direct and indirect sales channels to network operators. Ciena Corporation was founded in 1992 and is headquartered in Hanover, Maryland.

Tidewater Inc. (TDW) saw its value decrease by -8.97% as the stock dropped $-0.13 to finish the day at a closing price of $1.32. The stock was higher in trading and has fluctuated between $1.29-$11.58 per share for the past year. The shares, which traded within a range of $1.29 to $1.44 during the day, are down by -24.57% in the past three months and down by -59.26% over the past six months. It is currently trading -37.72% below its 20 day moving average and -55.55% below its 50 day moving average. Analysts believe the company can continue to increase in value to reach at $1.5 a share over the next twelve months. The current relative strength index (RSI) reading is 21.15.The technical indicator lead us to believe the stock will reverse recent losses any time soon.

Tidewater Inc. provides offshore service vessels and marine support services to the offshore energy industry through the operation of a fleet of marine service vessels worldwide. The company operates through Americas, Asia/Pacific, Middle East/North Africa, and Sub-Saharan Africa/Europe segments. It provides services in support of offshore exploration, field development, and production, including towing of and anchor handling for mobile offshore drilling units; transporting supplies and personnel necessary to sustain drilling, workover, and production activities; offshore construction, remotely operated vehicle (ROV) operations, and seismic and subsea support; and various specialized services, such as pipe and cable laying. The company operates and charters deepwater vessels, including platform supply vessels, and anchor handling towing supply vessels that are used in transporting supplies and equipment from shore bases to deepwater and intermediate water depth offshore drilling rigs and production platforms; towing-supply vessels for use in intermediate and shallow waters; and crew boats and utility vessels for use in transporting personnel and supplies from shore bases to offshore drilling rigs, platforms, and other installations. It also operates offshore tugs used for towing floating drilling rigs and barges; and assisting in the docking of tankers, as well as in pipe laying, cable laying, and construction barges. The company serves international oil and natural gas exploration, field development, and production companies; select independent exploration and production companies; foreign government-owned or government-controlled organizations and other companies; drilling contractors; and other companies, including offshore construction companies, diving companies, and well stimulation companies. As of March 31, 2016, it owned or chartered 269 vessels and 8 ROVs. Tidewater Inc. was founded in 1956 and is headquartered in New Orleans, Louisiana.

 

Trader Alert: Tonix Pharmaceuticals Holding Corp. (TNXP), B/E Aerospace, Inc. (BEAV), Gannett Co., Inc. (GCI)

Tonix Pharmaceuticals Holding Corp. (TNXP) grew with the stock adding 2.09% or $0.02 to close at $0.59 on active trading volume of 2.68M compared its three months average trading volume of 1.9M. The New York New York 10022 based company operating under the Drug Manufacturers – Major industry has been trending down for the last 52 weeks, with the shares price now -85.5% down for the period and up by 24.65% so far this year. With price target of $0 and a 66.48% rebound from 52-week low, Tonix Pharmaceuticals Holding Corp. has plenty of upside potential, making it a hold with a view buy.

Tonix Pharmaceuticals Holding Corp., a clinical-stage pharmaceutical company, develops medicines for common disorders of the central nervous system. The company’s lead program focuses on post-traumatic stress disorder (PTSD) that is characterized by chronic disability, inadequate treatment options, high utilization of healthcare services, and economic burden. Its lead product candidate includes TNX-102 SL, a cyclobenzaprine HCl sublingual tablet, a Phase III clinical stage for the treatment of PTSD; and Phase II clinical stage for the treatment of military-related PTSD. The company also develops TNX-301, a fixed dose combination drug product that contains disulfiram and selegiline for the treatment of alcohol use disorders, as well as biodefense development programs for protection from smallpox virus and radiation injury. Tonix Pharmaceuticals Holding Corp. was founded in 2007 and is based in New York, New York.

B/E Aerospace, Inc. (BEAV) gained $0.17 to close the day at a new closing price of $61.97, a 0.28% increase in value from its previous closing price that moved the stock 62.35% above its 52 week low of $39.71. A total of 2.67M shares exchanged hands during the day compared with its three month average trading volume of 1.6M. The stock, which fluctuated between $61.76 and $62.08 during the day, currently situated -0.11% below its 52 week high. The stock is up by 1.14% in the past one month and up by 5.82% over the past three months. With a one year target estimate of $60.92 and RSI of 67.11, the stock still has upside potential, making it a hold for now.

B/E Aerospace, Inc. designs, manufactures, sells, and services cabin interior products for commercial aircraft and business jets in the United States, Europe, Asia, Pacific Rim, the Middle East, and internationally. Its Commercial Aircraft segment offers first class, business class, tourist class, and regional aircraft seats, as well as spares; oxygen storage, distribution, and delivery systems for commercial and business jet aircraft; coffee makers/water boilers, ovens, and refrigeration equipment; and modular lavatory, wastewater management, and galley systems. This segment also provides engineering, design, integration, installation, and certification services for commercial aircraft passenger cabin interiors; services to design, manage, integrate, test, and certify reconfigurations and modifications for commercial aircraft, as well as to manufacture engineering kits and interface components; and interior reconfiguration services. The company’s Business Jet segment provides jet seating and sofa products, including electric fully berthing lie-flat seats, direct and indirect lighting, air valves, and oxygen delivery systems, as well as sidewalls, bulkheads, credenzas, closets, galley structures, lavatories, wastewater systems, and tables; super first class cabin interior products for commercial wide-body aircraft; and lightweight helicopter seats for double engine helicopter airframes for civil and military applications. It serves airlines; aircraft leasing companies; maintenance, repair, and overhaul providers; airframe manufacturers; and other commercial aircraft operators. The company was founded in 1987 and is headquartered in Wellington, Florida.

Gannett Co., Inc. (GCI) shares were down in last trading by -6.26% to $8.38. It experienced higher than average volume on day. The stock decreased in value by almost -14.58% over the past week and fell -14.4% in the past month. It is currently trading -13.53% below its 50 day moving average and -27.92% below its 200 day moving average. Following the recent decrease in price, the stock’s new closing price represents a -50.74% decrease in value from its one year high of $17.72. The RSI indicator value of 30.01, lead us to believe that it is a hold for now.

Gannett Co., Inc. operates as a multi-platform news and information company. The company’s operations comprise USA TODAY, a newspaper in print and digital circulation; 92 daily local publications in the United States and Guam; approximately 400 non-daily publications in the United States; and approximately 150 local news brands online, mobile, and in print in the United Kingdom. It also provides commercial printing, marketing, and data services. The company was formerly known as Gannett SpinCo, Inc. and changed its name to Gannett Co., Inc. in May 2015. Gannett Co., Inc. was incorporated in 2014 and is based in McLean, Virginia.

 

Stocks To Track: BorgWarner Inc. (BWA), Geron Corporation (GERN), Vista Outdoor Inc. (VSTO)

BorgWarner Inc. (BWA) climbed 0.1% during last trading as the stock added $0.04 to finish the day at $41.67 with about 2.29M shares changing hands, compared to its three month average trading volume of 2.25M. The $8.81B market cap company, which fluctuated between $41.39 and $42.18 during the day, currently situated 52.6% above its 52 week low of $27.52 and -0.74% away from its one year high of $42.18. The RSI of 60.66 indicates the stock is neither overvalued nor undervalued at the current levels, hold for now.

BorgWarner Inc. provides solutions for combustion, hybrid, and electric vehicles worldwide. The company operates through two segments, Engine and Drivetrain. The Engine segment develops and manufactures turbochargers; and timing systems, such as timing chains, variable cam timing products, crankshaft and camshaft sprockets, tensioners, guides and snubbers, HY-VO front-wheel drive transmission chains, and four-wheel drive chains for light vehicles. It also provides emissions systems, including electric air pumps and exhaust gas recirculation (EGR) modules, EGR coolers, EGR tubes, and EGR valves; thermal systems products comprising viscous fan drives, polymer fans, and coolant pumps; and glow plugs, diesel cold start systems, and other gasoline ignition technologies. The Drivetrain segment develops and manufactures friction and mechanical products, including dual and friction clutch modules, friction and steel plates, transmission bands, torque converter clutches, one-way clutches, and torsional vibration dampers. This segment also offers control products comprising electro-hydraulic solenoids, transmission solenoid modules, and dual clutch control modules; torque management products, such as rear-wheel drive/all-wheel drive (AWD) transfer case systems, front wheel drive-AWD coupling systems, and cross-axle coupling systems; and starter motors, alternators, and hybrid electric motors. The company sells its products to original equipment manufacturers of light vehicles consisting of passenger cars, sport-utility vehicles, vans, and light trucks; commercial vehicles, such as medium-duty and heavy duty trucks, and buses; and off-highway vehicles, including agricultural and construction machinery, and marine applications, as well as to tier one vehicle systems suppliers and the aftermarket for light, commercial, and off-highway vehicles. BorgWarner Inc. was founded in 1987 and is headquartered in Auburn Hills, Michigan.

Geron Corporation (GERN) gained $0.18 to close the day at a new closing price of $2.36, a 8.26% increase in value from its previous closing price that moved the stock 30.39% above its 52 week low of $1.81. A total of 2.27M shares exchanged hands during the day compared with its three month average trading volume of 1.25M. The stock, which fluctuated between $2.17 and $2.38 during the day, currently situated -29.55% below its 52 week high. The stock is up by 12.92% in the past one month and up by 10.28% over the past three months. With a one year target estimate of $4.38 and RSI of 69.94, the stock still has upside potential, making it a hold for now.

Geron Corporation, a clinical stage biopharmaceutical company, focuses on the development of telomerase inhibitor, imetelstat, for treating hematologic myeloid malignancies. It has collaboration and license agreement with Janssen Biotech, Inc. to develop and commercialize imetelstat worldwide for indications in oncology, including hematologic myeloid malignancies and other human therapeutic uses. The company was founded in 1990 and is based in Menlo Park, California.

Vista Outdoor Inc. (VSTO) had a active trading with around 2.26M shares changing hands compared to its three month average trading volume of 1.36M. The stock traded between $20.6 and $21.57 before closing at the price of $20.73 with -3.94% change on the day. The Farmington Utah 84025 based company is currently trading 5.12% above its 52 week low of $19.72 and -61.55% below its 52 week high of $53.91. Both the RSI indicator and target price of 19.29 and $33.25 respectively, lead us to believe that it could rise over the coming weeks.

Vista Outdoor Inc. designs, manufactures, and markets consumer products for the outdoor sports and recreation markets worldwide. The company’s Shooting Sports segment designs, develops, produces, and sources ammunition for the hunting and sport shooting enthusiast markets, as well as for local law enforcement, the United States government, and international markets under the Federal Premium, Speer, American Eagle, Blazer, CCI, Estate Cartridge, Stevens, Fusion, Savage Arms, Savage Range Systems, Force on Force, and Independence brands; and provides firearms products, such as centerfire rifles, rimfire rifles, shotguns, and range systems. Its Outdoor Products segment offers archery/hunting accessories, such as hunting arrows, game calls, hunting blinds, game cameras, and waterfowl decoys; eyewear and sport protection products comprising safety and protective eyewear, fashion and sports eyewear, and helmets; golf products, including laser rangefinders; and hydration products consisting of hydration packs and water bottles. This segment also offers optics products, such as binoculars, riflescopes, and telescopes; shooting accessories, including reloading equipment, clay targets, and premium gun care products; tactical products comprising holsters, duty gear, bags, and packs; and water sports products, such as stand up paddle boards. It provides its products under the Alliant Powder, Bee Stinger, BLACKHAWK!, Bollé, Bushnell, Butler Creek, CamelBak, Cébé, Champion Target, Eagle, Final Approach, Gold Tip, GunMate, Gunslick Pro, Hoppe’s, Jimmy Styks, M-Pro 7, Millett, Night Optics, Outers, Primos, RCBS, Redfield, Serengeti, Simmons, Stoney Point, Tasco, Uncle Mike’s, and Weaver brand names. The company sells its products to outdoor enthusiasts, hunters and recreational shooters, athletes, and law enforcement and military professionals through various mass, specialty, and independent retailers. The company was incorporated in 2014 and is headquartered in Farmington, Utah.

 

Stocks Roundup: KB Home (KBH), Olin Corporation (OLN), Juno Therapeutics, Inc. (JUNO)

KB Home (KBH) retreated with the stock falling -1.15% or $-0.19 to close at $16.36 on light trading volume of 2.12M compared its three months average trading volume of 2.47M. The Los Angeles California 90024 based company operating under the Residential Construction industry has been trending up for the last 52 weeks, with the shares price now 61.3% up for the period and up by 3.64% so far this year. With price target of $16.64 and a 76.33% rebound from 52-week low, KB Home has plenty of upside potential, making it a hold with a view buy.

KB Home operates as a homebuilding company in the United States. It builds and sells various homes, including attached and detached single-family residential homes, townhomes, and condominiums primarily for first-time, move-up, and active adult homebuyers. The company also provides property and casualty insurance, as well as earthquake, flood, and personal property insurance to its homebuyers; title services; and mortgage banking services, including residential mortgage loan originations to its homebuyers. It has operations in California, Arizona, Nevada, Colorado, Texas, Florida, and North Carolina, The company was formerly known as Kaufman and Broad Home Corporation and changed its name to KB Home in January 2001. KB Home was founded in 1957 and is headquartered in Los Angeles, California.

Olin Corporation (OLN) had a light trading with around 2.11M shares changing hands compared to its three month average trading volume of 2.22M. The stock traded between $29.88 and $30.33 before closing at the price of $29.93 with 0.4% change on the day. The Clayton Missouri 63105 based company is currently trading 147.67% above its 52 week low of $12.78 and -2.38% below its 52 week high of $30.87. Both the RSI indicator and target price of  and $29.33 respectively, lead us to believe that it could rise over the coming weeks.

Olin Corporation manufactures and distributes chemical products in the United States and internationally. It operates through three segments: Chlor Alkali Products and Vinyls, Epoxy, and Winchester. The Chlor Alkali Products and Vinyls segment offers chlorine and caustic soda, ethylene dichloride and vinyl chloride monomers, methyl chloride, methylene chloride, chloroform, carbon tetrachloride, perchloroethylene, trichloroethylene and vinylidene chloride, hydrochloric acid, hydrogen, bleach products, and potassium hydroxide. The Epoxy segment provides allyl chloride and epichlorohydrin for use in resins and other plastic materials, water purification, and pesticides, as well as for the manufacturers of polymers; liquid epoxy resins used in adhesives, paints and coatings, composites, and flooring; and converted epoxy resins and additives for use in electrical laminates, paints and coatings, wind blades, electronics, and construction. The Winchester segment offers sporting ammunition, law enforcement ammunition, reloading components, small caliber military ammunition and components, and industrial cartridges. The company markets its products through its sales force, as well as directly to various industrial customers, mass merchants, retailers, wholesalers, other distributors, and the U.S. Government and its prime contractors. Olin Corporation was founded in 1892 and is headquartered in Clayton, Missouri.

Juno Therapeutics, Inc. (JUNO) saw its value increase by 0.73% as the stock gained $0.16 to finish the day at a closing price of $22.11. The stock was higher in trading and has fluctuated between $17.52-$49.72 per share for the past year. The shares, which traded within a range of $21.81 to $22.91 during the day, are down by -26.64% in the past three months and down by -32.3% over the past six months. It is currently trading 8.06% above its 20 day moving average and 12.01% above its 50 day moving average. Analysts believe the company can continue to increase in value to reach at $30.5 a share over the next twelve months. The current relative strength index (RSI) reading is 63.65.The technical indicator lead us to believe there will be no major movement any time soon, hold.

Juno Therapeutics, Inc., a biopharmaceutical company, engages in developing cell-based cancer immunotherapies. The company develops cell-based cancer immunotherapies based on its chimeric antigen receptor and T cell receptor technologies to genetically engineer T cells to recognize and kill cancer cells. Its clinical stage CD19 product candidates include JCAR015 that is in Phase II clinical trials for adult patients with relapsed/refractory B cell acute lymphoblastic leukemia (r/r ALL); JCAR017, which is in Phase I/II trials for pediatric patients with r/r ALL; and JCAR014 that is in Phase I/II trials to treat various B cell malignancies in patients relapsed or refractory to standard therapies. The company’s additional product candidates comprise CD22, a cell surface protein expressed on B lymphocytes; CD171, a cell-surface adhesion molecule to treat neuroblastoma; MUC-16, a protein for treating ovarian cancers; IL-12, a cytokine to overcome the inhibitory effects; ROR-1, a protein for the treatment of non-small cell lung, triple negative breast, pancreatic, and prostate cancers; and WT-1, an intracellular protein that is in Phase I/II clinical trials to treat adult myeloid leukemia and non-small cell lung, breast, pancreatic, ovarian, and colorectal cancers. Juno Therapeutics, Inc. has collaboration agreements with Celgene Corporation, Editas Medicine, Inc., Fate Therapeutics, Inc., MedImmune Limited, and Memorial Sloan Kettering Cancer Center. The company was formerly known as FC Therapeutics, Inc. and changed its name to Juno Therapeutics, Inc. in October 2013. Juno Therapeutics, Inc. was founded in 2013 and is headquartered in Seattle, Washington.

 

Stocks Alert: Newfield Exploration Company (NFX), Actinium Pharmaceuticals, Inc. (ATNM), Sprouts Farmers Market, Inc. (SFM)

Newfield Exploration Company (NFX) grew with the stock adding 0.55% or $0.23 to close at $42 on light trading volume of 2.01M compared its three months average trading volume of 2.39M. The The Woodlands Texas 77380 based company operating under the Independent Oil & Gas industry has been trending up for the last 52 weeks, with the shares price now 73.77% up for the period and up by 3.7% so far this year. With price target of $53.33 and a 101.54% rebound from 52-week low, Newfield Exploration Company has plenty of upside potential, making it a hold with a view buy.

Newfield Exploration Company, an independent energy company, engages in the exploration, development, and production of crude oil, natural gas, and natural gas liquids in the United States. Its principal areas of operation include the Anadarko and Arkoma basins of Oklahoma, the Williston Basin of North Dakota, the Uinta Basin of Utah, and the Maverick and Gulf Coast basins of Texas. The company also holds offshore oil developments in China. As of December 31, 2015, it had proved reserves of approximately 509 million barrels of oil equivalent. The company was founded in 1988 and is headquartered in The Woodlands, Texas.

Actinium Pharmaceuticals, Inc. (ATNM) dropped $-0.03 to close the day at a new closing price of $1.48, a -1.99% decrease in value from its previous closing price that moved the stock 72.09% above its 52 week low of $0.86. A total of 1.99M shares exchanged hands during the day compared with its three month average trading volume of 524.02K. The stock, which fluctuated between $1.3 and $1.56 during the day, currently situated -37.29% below its 52 week high. The stock is up by 49.49% in the past one month and up by 40.95% over the past three months. With a one year target estimate of $7.33 and RSI of 69.92, the stock still has upside potential, making it a hold for now.

Actinium Pharmaceuticals, Inc., a biopharmaceutical company, develops targeted payload immunotherapeutics for the treatment of advanced cancers. The company’s targeted radio immunotherapy products are based on its proprietary delivery platform for the therapeutic utilization of alpha-emitting Actinium-225 and Bismuth-213, and certain beta emitting radiopharmaceuticals in conjunction with monoclonal antibodies. Its lead radiopharmaceutical product candidate is Iomab-B that is in Phase 3 clinical studies in refractory or relapsed acute myeloid leukemia (AML) patients over the age of 55 for hematopoietic stem cell transplant, commonly referred to as bone marrow transplant. The company is also developing Actimab-A, which is in Phase 1/2 clinical trials for patients newly diagnosed with AML over the age of 60 in a single-arm multicenter trial. Actinium Pharmaceutical, Inc. was founded in 2000 and is headquartered in New York, New York.

Sprouts Farmers Market, Inc. (SFM) shares were down in last trading by -2.36% to $19.06. It experienced lighter than average volume on day. The stock increased in value by almost 2.86% over the past week and fell -1.55% in the past month. It is currently trading -2.94% below its 50 day moving average and -12.96% below its 200 day moving average. Following the recent decrease in price, the stock’s new closing price represents a -36.47% decrease in value from its one year high of $30. The RSI indicator value of 49.33, lead us to believe that it is a hold for now.

Sprouts Farmers Market, Inc., together with its subsidiaries, operates as a retailer of fresh, natural, and organic food in the United States. The company’s retail stores offer fresh produce, bulk foods, vitamins and supplements, grocery, meat and seafood, deli, bakery, dairy, frozen foods, body care and natural household items, beer and wine, and dairy alternatives. As of November 3, 2016, it operated 252 stores in 13 states. Sprouts Farmers Market, Inc. was founded in 2002 and is headquartered in Phoenix, Arizona.

 

Stocks To Watch: F.N.B. Corporation (FNB), Provectus Biopharmaceuticals, Inc. (PVCT), The Finish Line, Inc. (FINL)

F.N.B. Corporation (FNB) traded within a range of $14.98 to $15.28 after opening the day at $15.05. The company has seen its stock decrease in value by -5.99% so far this year. The stock was up close to 0.74% on light volume in last trading session and closed at $15.07 per share. After the recent gain, the stock is currently holding -8.28% below its 52 week high of $16.43 and 36.62% above its 12-month low of $11.69. The shares are up by over 8.05% in the last three months, and the RSI indicator value of 47.43 is neither bullish nor bearish, tempting investors to stay on the sidelines.

F.N.B. Corporation, a financial holding company, provides a range of financial services to consumers, corporations, governments, and small- to medium-sized businesses primarily in Pennsylvania, eastern Ohio, and northern West Virginia. It operates through four segments: Community Banking, Wealth Management, Insurance, and Consumer Finance. The Community Banking segment offers various deposit products, such as commercial and individual demand, savings, and time deposit accounts; and commercial, mortgage, and individual installment loans. The Wealth Management segment provides a range of personal and corporate fiduciary services, including the administration of decedent and trust estates; investment products and services for customers through a networking relationship with a third-party licensed brokerage firm; and investment programs consisting of mutual funds, annuities, stocks, and bonds for individuals, corporations, and retirement funds, as well as community banking customers. The Insurance segment operates as a full-service insurance brokerage agency that offers commercial and personal insurance products through various carriers to businesses and individuals; acts as a reinsurer to underwrite credit life, and accident and health insurance products; and provides title insurance products. The Consumer Finance segment is primarily involved in making personal installment loans to individuals; and purchasing installment sales finance contracts from retail merchants. The company also offers mezzanine financing options for small-to medium-sized businesses; and new or used equipment commercial loans and leasing services. As of December 31, 2015, it had 288 community banking offices in Pennsylvania, Ohio, Maryland, and West Virginia; and 76 consumer finance offices in Pennsylvania, Ohio, Tennessee, and Kentucky. F.N.B. Corporation was founded in 1974 and is headquartered in Pittsburgh, Pennsylvania.

Provectus Biopharmaceuticals, Inc. (PVCT) managed to rebound with the stock declining 16.96% or $0 to close the day at $0.02 on light trading volume of 1.96M shares, compared to its three month average trading volume of 4.28M. The Knoxville Tennessee 37931 based company has been underperforming the drug manufacturers – major group over the past 52 weeks, with the stock losing -95.35%, compared to the industry which has advanced 13.25% over the same period. With RSI of 57.51, the stock should still continue to rise and get closer to its one year target estimate of $3.5, making it a hold for now.

Provectus Biopharmaceuticals, Inc., a biopharmaceutical company, engages in developing ethical pharmaceuticals for oncology and dermatology indications. Its prescription drug candidates includes PV-10, which is in Phase III study for cutaneous melanoma; completed Phase II study for metastatic melanoma; completed Phase I study for liver and breast cancers; and phase 1b/2 study for pembrolizumab. The company is also developing PH-10 that has completed Phase II randomized study for the treatment of psoriasis and atopic dermatitis. In addition, it develops PH-10 for the treatment of actinic keratosis and severe acne vulgaris. Further, the company is developing over-the-counter pharmaceuticals, including GloveAid, a hand cream with antiperspirant and antibacterial properties; Pure-ific line of products to prevent the spread of germs on skin; and Pure-Stick and Pure N Clear acne products. Additionally, it develops medical device technologies for markets comprising cosmetic treatments, such as reduction of wrinkles and elimination of spider veins, and other cosmetic blemishes; and therapeutic uses, including photoactivation of PH-10, other prescription drugs, and non-surgical destruction of various skin cancers. The company was formerly known as Provectus Pharmaceuticals, Inc. and changed its name to Provectus Biopharmaceuticals, Inc. in December 2013. Provectus Biopharmaceuticals, Inc. was founded in 2002 and is based in Knoxville, Tennessee.

The Finish Line, Inc. (FINL) dropped $-0.05 to close the day at a new closing price of $17.89, a -0.28% decrease in value from its previous closing price that moved the stock 8.43% above its 52 week low of $16.55. A total of 1.95M shares exchanged hands during the day compared with its three month average trading volume of 1.49M. The stock, which fluctuated between $17.83 and $18.3 during the day, currently situated -26.98% below its 52 week high. The stock is up by 3.17% in the past one month and down by -14.44% over the past three months. With a one year target estimate of $20.53 and RSI of 46.26, the stock still has upside potential, making it a hold for now.

The Finish Line, Inc., together with its subsidiaries, operates as a specialty retailer of athletic shoes, apparel, and accessories in the United States. It operates in two divisions, the Finish Line and JackRabbit. The company’s Finish Line division engages in the in-store and online retail of athletic shoes for Macy’s Retail Holdings, Inc.; Macy’s Puerto Rico, Inc.; and Macys.com, Inc., as well as online at macys.com. This division offers men’s, women’s, and kids’ athletic shoes, as well as an assortment of accessories of Nike, Skechers, Converse, Puma, New Balance, Adidas, and other brands. As of April 2, 2016, the company operated Finish Line shops in 392 Macy’s department stores in 37 states in the United States, the District of Columbia, and Puerto Rico. Its JackRabbit division retails lifestyle products, such as running shoes, apparel, and accessories of Brooks, Asics, Nike, Saucony, New Balance, and other brands. It also operates the e-commerce sites jackrabbit.com and boulderrunningcompany.com. The company operated 72 JackRabbit stores in 17 states in the United States and the District of Columbia. The company also offers products through its e-commerce site, finishline.com and mobile commerce site, m.finishline.com. The company was founded in 1976 and is based in Indianapolis, Indiana.

 

Stocks in the Spotlight: Immune Pharmaceuticals, Inc. (IMNP), RXi Pharmaceuticals Corporation (RXII), Service Corporation International (SCI)

Immune Pharmaceuticals, Inc. (IMNP) had a light trading with around 1.63M shares changing hands compared to its three month average trading volume of 5.77M. The stock traded between $0.1855 and $0.1949 before closing at the price of $0.19 with 1.11% change on the day. The New York New York 10016 based company is currently trading 22.82% above its 52 week low of $0.1551 and -70.23% below its 52 week high of $0.64. Both the RSI indicator and target price of 46.58 and $3 respectively, lead us to believe that it should be put on hold over the coming weeks.

Immune Pharmaceuticals, Inc., a clinical stage biopharmaceutical company, develops and commercializes novel targeted therapeutics in the immuno-inflammation and immuno-oncology areas. The company’s lead product candidate is Bertilimumab, a human monoclonal antibody, which is in Phase II clinical trial for the treatment of ulcerative colitis, bullous pemphigoid, and Crohn’s disease. It is also developing NanoCyclo, a topical nanocapsule formulation of cyclosporine, for the treatment of psoriasis and atopic dermatitis; Ceplene, a small molecule, which has completed Phase III clinical trials targeting the Histamine-2 Receptor to overcome immunosuppression in Acute Myeloid Leukemia and other malignancies; Azixa, a Phase II clinical trial novel microtubular destabilizer that functions as a vascular disruption agent; and Crolibulin, a novel small molecule vascular disruption agent and apoptosis inducer, which is in Phase II clinical trials for the treatment of patients with solid tumors. The company’s products also include NanomAbs technology platform, an antibody-drug conjugate platform for the treatment of cancer; novel technology platform for the construction of bispecific antibodies for immunotherapies; and AmiKet, a prescription topical analgesic cream, which is in Phase III clinical trial to treat peripheral neuropathies. It has license, and other collaborative research and development arrangements with BioNanoSim Ltd.; Yissum Research Development Company of The Hebrew University of Jerusalem Ltd.; Atlante Biotech SAS; Shire Biochem, Inc.; Lonza Sales AG; MabLife SAS; iCo Therapeutics Inc.; Dalhousie University; and Endo Pharmaceuticals Inc. Immune Pharmaceuticals, Inc. was founded in 2010 and is headquartered in New York, New York.

RXi Pharmaceuticals Corporation (RXII) managed to rebound with the stock declining -0.5% or $0 to close the day at $0.76 on light trading volume of 1.62M shares, compared to its three month average trading volume of 972.48K. The  based company has been underperforming the biotechnology group over the past 52 weeks, with the stock losing -72.86%, compared to the industry which has dropped -1.43% over the same period. With RSI of 44.57, the stock should still continue to rise and get closer to its one year target estimate of $8, making it a hold for now.

RXi Pharmaceuticals Corporation, a clinical-stage RNAi company, focuses on discovering and developing therapies primarily in the areas of dermatology and ophthalmology. The company develops therapies based on siRNA technology and immunotherapy agents. Its clinical development programs include RXI-109, a self-delivering RNAi compound, which is in Phase IIa clinical trial that is used to prevent or reduce dermal scarring following surgery or trauma, as well as for the management of hypertrophic scars and keloids; and a Phase I/II clinical trial in retinal scarring. It is also developing RXI-109 for the treatment of an ophthalmic indication, focusing on retinal and corneal scarring; and Samcyprone, a formulation of diphenylcyclopropenone, which is in Phase II clinical trial for the treatment of various disorders, such as warts, alopecia areata, non-malignant skin tumors, and cutaneous metastases of melanoma. In addition, the company is developing dermal scarring and wart programs with its sd-rxRNA technology. The company was incorporated in 2011 and is headquartered in Marlborough, Massachusetts.

Service Corporation International (SCI) shares were up in last trading by 0.31% to $29.55. It experienced higher than average volume on day. The stock increased in value by almost 1.09% over the past week and grew 2.32% in the past month. It is currently trading 4.03% above its 50 day moving average and 9.46% above its 200 day moving average. Following the recent increase in price, the stock’s new closing price represents a -0.17% decrease in value from its one year high of $29.72. The RSI indicator value of 66.2, lead us to believe that it is a hold for now.

Service Corporation International, together with its subsidiaries, provides deathcare products and services in the United States and Canada. The company operates through Funeral and Cemetery segments. Its funeral service and cemetery operations comprise funeral service locations, cemeteries, funeral service/cemetery combination locations, crematoria, and related businesses. The company also provides professional services relating to funerals and cremations, including the use of funeral facilities and motor vehicles; arranging and directing services; and removal, preparation, embalming, and cremation services, as well as catering services. In addition, it offers funeral merchandise, including burial caskets and related accessories, urns and other cremation receptacles, outer burial containers, flowers, on-line and video tributes, stationery products, casket and cremation memorialization products, and other merchandise. Further, the company’s cemeteries provide cemetery property interment rights, including developed lots, lawn crypts, mausoleum spaces, niches, and other cremation memorialization and interment options; and sells cemetery merchandise and services, including memorial markers and bases, floral placements, graveside services, merchandise installation, and burial openings and closings, as well as offers preneed cemetery merchandise and services. Service Corporation International offers its products and services under the Dignity Memorial, Dignity Planning, National Cremation Society, Advantage, Funeraria del Angel, Making Everlasting Memories, Neptune Society, and Trident Society brands. As of December 31, 2015, it operated 1,535 funeral service locations; and 469 cemeteries, including 262 funeral service/cemetery combination locations covering 45 states, 8 Canadian provinces, the District of Columbia, and Puerto Rico. The company was founded in 1962 and is headquartered in Houston, Texas.